Patients
Rare diseases, real opportunity: Why the UK’s next challenge...
The UK has the science, the talent, and the investment. The next step is ensuring that innovation translates into timely patient impact.
Market Access
Is the next generation of Chinese biotech ready to go global...
Will Chinese biotechs continue to transfer most ex-China rights, or retain their strongest assets and compete internationally themselves?
Sales & Marketing
The independent pharmacy opportunity pharma marketers are ov...
Pharma marketers often underestimate the value of independent pharmacies.
R&D
Sponsored
Turning recruitment potential into enrolment reality
In the fourth episode of the IQVIA-sponsored PSCS leadership video series, Karen Townsend, senior director of medical affairs discusses SEELs
Oncology
Australia, CAR-T therapy, and solid tumours
Bev Menner, chief executive officer at Cell Therapies Pty Ltd, discusses CAR-T therapies for solid tumours and Australian and APAC R&D more generally.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
